Panbela Therapeutics, Inc. Quarterly Preferred Stock, Shares Authorized from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Panbela Therapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q4 2011 to Q3 2024.
  • Panbela Therapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending September 30, 2024 was 10M shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 10M 0 0% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 10M 0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 10M 0 0% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 10M 0 0% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 10M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 10M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 10M 0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 10M 0 0% Dec 31, 2022 10-K 2024-03-26
Q3 2022 10M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 10M 0 0% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 10M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 10M 0 0% Dec 31, 2021 10-K 2023-03-16
Q3 2021 10M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 10M 0 0% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 10M 0 0% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 10M 0 0% Dec 31, 2020 10-Q 2021-11-10
Q3 2020 10M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 10M 0 0% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 10M 0 0% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 10M 0 0% Dec 31, 2019 10-K 2021-03-25
Q3 2019 10M 0 0% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 10M 0 0% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 10M 0 0% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 10M 0 0% Dec 31, 2018 10-K 2020-03-24
Q3 2018 10M 0 0% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 10M -10M -50% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 10M -10M -50% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 10M 0 0% Dec 31, 2017 10-K 2019-03-22
Q3 2017 10M -10M -50% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 20M 0 0% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 20M +10M +100% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 10M 0 0% Dec 31, 2016 10-K 2018-03-21
Q3 2016 20M +10M +100% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 20M +19.5M +3900% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 10M +9.5M +1900% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 10M +5M +100% Dec 31, 2015 10-K 2017-03-30
Q3 2015 10M +9.5M +1900% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 500K 0 0% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 500K 0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 5M +4.5M +900% Dec 31, 2014 10-K 2016-03-08
Q3 2014 500K 0 0% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 500K 0 0% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 500K 0 0% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 500K 0 0% Dec 31, 2013 10-K 2015-03-30
Q3 2013 500K Sep 30, 2013 10-Q 2013-11-14
Q2 2013 500K Jun 30, 2013 10-Q 2013-08-14
Q1 2013 500K Mar 31, 2013 10-Q 2013-05-15
Q4 2012 500K 0 0% Dec 31, 2012 10-K 2014-03-28
Q4 2011 500K Dec 31, 2011 10-K 2013-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.